Contact information
Awards & QUALIFICATIONS
- The Ruskell Medal, The Worshipful Company of Spectacle Makers, 2021
- The Founder's Cup, Oxford Ophthalmological Congress, 2018
- Fellow of the Royal College of Ophthalmologists, 2016
- MRC/Fight for Sight Clinical Research Training Fellowship, 2015
- Crombie Medal, Royal College of Ophthalmologists 2011
- BM BCh with Distinction, University of Oxford 2010
- MA (First Class), University of Cambridge 2007
- Swann Prize for Biology, Gonville & Caius College, Cambridge 2007
- Ian Gordon-Smith Prize for Medicine, Gonville & Caius College, Cambridge 2005
Harry Orlans
MA (Cantab) BM BCh DPhil FRCOphth
Clinical Research Fellow
- Specialist Registrar and Locum Consultant (Accident & Emergency), Moorfields Eye Hospital, London
Harry's background is in Clinical Ophthalmology as a Specialist Registrar within the North London/Moorfields Eye Hospital training rotation.
Harry's research focusses on developing a new gene-therapy based treatment for dominant retinitis pigmentosa (RP) caused by defects in the rhodopsin gene. These mutations account for around a quarter of all cases of dominant RP and are one of the most common genetic cause of sight loss in the UK.
Research groups
Collaborators
-
Robert MacLaren
Professor of Ophthalmology
Recent publications
-
Journal article
Corazza P. et al, (2020), Ophthalmologica
-
Journal article
Orlans HO. et al, (2020), Exp Eye Res, 190
-
Journal article
Orlans HO. and MacLaren RE., (2019), Eye (Lond)
-
Filtration of short-wavelength light provides therapeutic benefit in Retinitis Pigmentosa caused by a common rhodopsin mutation.
Journal article
(2019), Investigative ophthalmology and Visual Science
-
Mirtron gene therapy for the treatment of rhodopsin-related dominant retinitis pigmentosa
Conference paper
Orlans HO. et al, (2019), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 60